Abstract
CyPep-1 is a synthetic tumor membrane targeting 27-D-aminoacid alpha-helical peptide. Preclinical studies with CyPep-1 have demonstrated immunogenic cell death and synergism with anti-PD1 antibodies. The dose-escalation part of this study assessed safety and determined the recommended dose for further development (RP2D).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
